1. Home
  2. BNR vs NCO Comparison

BNR vs NCO Comparison

Compare BNR & NCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$13.00

Market Cap

141.5M

Sector

Health Care

ML Signal

N/A

NCO

Southern Cross Acquisition I Corp. Ordinary Shares

N/A

Current Price

$9.97

Market Cap

146.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
NCO
Founded
2014
2025
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
146.0M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
BNR
NCO
Price
$13.00
$9.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 23.4K
16.6K
Earning Date
11-23-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$101.46
N/A
Revenue Next Year
$14.81
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$9.83
52 Week High
$41.72
$9.97

Technical Indicators

Market Signals
Indicator
BNR
NCO
Relative Strength Index (RSI) 51.21 69.93
Support Level $9.12 $9.90
Resistance Level $19.10 N/A
Average True Range (ATR) 1.26 0.01
MACD 0.16 0.00
Stochastic Oscillator 88.67 100.00

Price Performance

Historical Comparison
BNR
NCO

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About NCO Southern Cross Acquisition I Corp. Ordinary Shares

Southern Cross Acquisition I Corp is a blank check company formed for the purpose of effecting into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

Share on Social Networks: